Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.

Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-19 · accession 0001209191-21-066123 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-11-22	2021-11-19	ARWR	San Martin Javier	Chief Medical Off	S - Sale	$69.31	-19.5K	111.0K	-15%	-$1.35M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-11-19	S	D	13,704	$69.01	116,796	D	—	—	(F2) The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.54 to $69.53, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
2	Common	Common Stock	2021-11-19	S	D	5,696	$70.01	111,100	D	—	—	(F3) The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.54 to $70.36, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
3	Common	Common Stock	2021-11-19	S	D	100	$70.99	111,000	D	—	—	(F4) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.